Rhodamine–Herceptin generated in this way bound metastatic breast adenocarcinoma HER2(+) cells (SK‐BR‐3) selectively (no binding to HER2(−) MCF‐7 cells), as shown by fluorescence‐activated cell sorting (Figure 6). This evidence concerns the gene ERBB2 and breast adenocarcinoma.